Cargando…
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer
PURPOSE: To provide an overview of model characteristics and outcomes of model-based economic evaluations concerning chemotherapy and targeted therapy (TT) for metastatic breast cancer (MBC); to assess the quality of the studies; to analyse the association between model characteristics and study qua...
Autores principales: | Pouwels, Xavier Ghislain Léon Victor, Ramaekers, Bram L. T., Joore, Manuela A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602061/ https://www.ncbi.nlm.nih.gov/pubmed/28689361 http://dx.doi.org/10.1007/s10549-017-4374-6 |
Ejemplares similares
-
Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study
por: Petersohn, Svenja, et al.
Publicado: (2020) -
Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models
por: Grimm, Sabine E., et al.
Publicado: (2019) -
State of the ART? Two New Tools for Risk Communication in Health Technology Assessments
por: Grimm, Sabine E., et al.
Publicado: (2021) -
Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to “TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases”)
por: Grimm, Sabine E., et al.
Publicado: (2021) -
Correction to: Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to “TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases”)
por: Grimm, Sabine E., et al.
Publicado: (2021)